Back to Journals » Drug, Healthcare and Patient Safety » Volume 16 » default
Drug, Healthcare and Patient Safety
- View all (328)
- Volume 18, 2026 (14)
- Volume 17, 2025 (21)
- Volume 16, 2024 (15)
- Volume 15, 2023 (16)
- Volume 14, 2022 (19)
- Volume 13, 2021 (25)
- Volume 12, 2020 (35)
- Volume 11, 2019 (15)
- Volume 10, 2018 (12)
- Volume 9, 2017 (11)
- Volume 8, 2016 (13)
- Volume 7, 2015 (20)
- Volume 6, 2014 (22)
- Volume 5, 2013 (23)
- Volume 4, 2012 (18)
- Volume 3, 2011 (15)
- Volume 2, 2010 (25)
- Volume 1, 2009 (9)
Archive: Volume 16, 2024
A Cross-Sectional Evaluation of Opioid Dispensing Competencies in Final-Year Pharm-D Students: A Multicenter Study from Punjab, Pakistan
Mubarak N, Rahman Rana F, Zahid T, Ijaz UEB, Shabbir A, Ghulam Bari A, Niaz B, Kanwal S, Saif-Ur-Rahman N, Iqbal Z, Khan AM, Zin CS, Mahmood K, Elnaem MH, Tariq S
Drug, Healthcare and Patient Safety 2024, 16:133-144
Published Date: 28 December 2024
Predictors of Using Pharmacists as a Medication Safety Information Resource Among Women of Reproductive Age
Awuonda MK, Alem G, Olbert B, Reddy M, Daftary M, Wingate L, Ettienne E
Drug, Healthcare and Patient Safety 2024, 16:125-132
Published Date: 7 December 2024
The Impact of Sacubitril/Valsartan on Heart Failure Patient with Reduced Left Ventricular Ejection Fraction: Single Center Retrospective Study in Saudi Arabia
Al Raddadi S, Almutairi M, AlAamer K, Alsalman A, Albalawi M, Almeshary M, Badreldin HA, Almodaimegh H
Drug, Healthcare and Patient Safety 2024, 16:117-124
Published Date: 30 September 2024
Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone [Response to Letter]
Thomas F, Abiri OT, Kallon JM, Kangbai DM, Conteh TA, Conteh SM, Samuels EG, Awodele O
Drug, Healthcare and Patient Safety 2024, 16:115-116
Published Date: 29 September 2024
Baloxavir Resistance Markers in Influenza A and B Viruses in the Americas
Acocal-Juárez E, Márquez-Domínguez L, Vallejo-Ruíz V, Cedillo L, Santos-López G
Drug, Healthcare and Patient Safety 2024, 16:105-113
Published Date: 14 September 2024
Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone [Letter]
Rahman NE
Drug, Healthcare and Patient Safety 2024, 16:103-104
Published Date: 4 September 2024
Adverse Drug Reactions Related with Antibiotic Medicines in Malawi: A Retrospective Analysis of Prevalence and Associated Factors
Chiumia FK, Chimimba F, Nyirongo HM, Kampira EL, Muula AS, Khuluza F
Drug, Healthcare and Patient Safety 2024, 16:89-101
Published Date: 23 July 2024
Medication-Related Hospital Admission Among Patients Admitted to the Emergency Ward at the University of Gondar, North West Ethiopia: A Cross Sectional Study
Gebremariam SN, Sema FD, Jara AG, Mekonnen GA
Drug, Healthcare and Patient Safety 2024, 16:75-88
Published Date: 17 July 2024
Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone
Thomas F, Abiri OT, Kallon JM, Kangbai DM, Conteh TA, Conteh SM, Samuels EG, Awodele O
Drug, Healthcare and Patient Safety 2024, 16:61-73
Published Date: 19 June 2024
Therapeutic Potential of Treprostinil Inhalation Powder for Patients with Pulmonary Arterial Hypertension: Evidence to Date
Cassady SJ, Almario JAN, Ramani GV
Drug, Healthcare and Patient Safety 2024, 16:51-59
Published Date: 5 June 2024
Rapid Onset and Recovery Linezolid-Induced Thrombocytopenia: A Large-Sample, Single-Center Retrospective Cohort Study
AL Qamariat Z, Aljaffar AA, Alabdulaal ZS, Alnezir F, Al-Zawad WM, Alqattan M, Almahdi A
Drug, Healthcare and Patient Safety 2024, 16:43-49
Published Date: 21 May 2024
Response to Osilodrostat Therapy in Adrenal Cushing’s Syndrome
Stasiak M, Witek P, Adamska-Fita E, Lewiński A
Drug, Healthcare and Patient Safety 2024, 16:35-42
Published Date: 8 April 2024
Obstructive Fibrinous Tracheal Pseudomembrane Following Repeated Intratracheal Interventions
Tang W, Zhou W, Zheng X
Drug, Healthcare and Patient Safety 2024, 16:29-33
Published Date: 6 March 2024
Evaluation of Seven Different Brands of Metformin Hydrochloride Tablets Available in the Market in Gondar City, Ethiopia
Flatie Alemu A, Tegegne AA, Getaw NS
Drug, Healthcare and Patient Safety 2024, 16:19-28
Published Date: 1 February 2024
Validity of Routine Health Data To Identify Safety Outcomes of Interest For Covid-19 Vaccines and Therapeutics in the Context of the Emerging Pandemic: A Comprehensive Literature Review
Andresen K, Hinojosa-Campos M, Podmore B, Drysdale M, Qizilbash N, Cunnington M
Drug, Healthcare and Patient Safety 2024, 16:1-17
Published Date: 3 January 2024